Cormark Has Bearish Estimate for TSE:TRU FY2026 Earnings

Trulieve Cannabis Corp. (TSE:TRUFree Report) – Analysts at Cormark lowered their FY2026 EPS estimates for shares of Trulieve Cannabis in a research note issued on Thursday, May 8th. Cormark analyst J. Pytlak now expects that the company will post earnings per share of $0.08 for the year, down from their previous estimate of $0.11. Cormark has a “Moderate Buy” rating on the stock.

Several other research firms have also issued reports on TRU. Roth Capital upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a report on Monday, March 3rd. Craig Hallum raised shares of Trulieve Cannabis to a “strong-buy” rating in a research report on Wednesday, February 26th.

Read Our Latest Analysis on TRU

Trulieve Cannabis Price Performance

Trulieve Cannabis Company Profile

(Get Free Report)

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.

Further Reading

Earnings History and Estimates for Trulieve Cannabis (TSE:TRU)

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.